Annals of the Rheumatic Diseases: 81 (9)

Viewpoint

Developing guidelines for ultrarare rheumatic disorders: a bumpy ride (23 June, 2022)
David Piskin, Micol Romano, Daniel Aletaha, Brian M Feldman, Raphaela Goldbach-Mansky, Loreto Carmona, Erkan Demirkaya

Rheumatoid arthritis

Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis (27 May, 2022)
Serena Bugatti, Ludovico De Stefano, Bernardo D’Onofrio, Andrea Nicrosini, Eleonora Mauric, Michele di Lernia, Garifallia Sakellariou, Ennio Giulio Favalli, Antonio Manzo, Roberto Caporali, Carlomaurizio Montecucco
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming (9 June, 2022)
Faye A H Cooles, Jessica Tarn, Dennis W Lendrem, Najib Naamane, Chung MA Lin, Ben Millar, Nicola J Maney, Amy E Anderson, Nishanthi Thalayasingam, Julie Diboll, Vincent Bondet, Darragh Duffy, Michael R Barnes, Graham R Smith, Sandra Ng, David Watson, Rafael Henkin, Andrew P Cope, Louise N Reynard, Arthur G Pratt, RA-MAP Consortium, John D Isaacs
Distinct stromal and immune cell interactions shape the pathogenesis of rheumatoid and psoriatic arthritis (14 June, 2022)
Achilleas Floudas, Conor M Smith, Orla Tynan, Nuno Neto, Vinod Krishna, Sarah M Wade, Megan Hanlon, Clare Cunningham, Viviana Marzaioli, Mary Canavan, Jean M Fletcher, Ronan H Mullan, Suzanne Cole, Ling-Yang Hao, Michael G Monaghan, Sunil Nagpal, Douglas J Veale, Ursula Fearon

Spondyloarthritis

MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group (24 May, 2022) Free
Xenofon Baraliakos, Mikkel Østergaard, Robert GW Lambert, Iris Eshed, Pedro M Machado, Susanne Juhl Pedersen, Ulrich Weber, Manouk de Hooge, Joachim Sieper, Denis Poddubnyy, Martin Rudwaleit, Désirée van der Heijde, Robert BM Landewé, Walter P Maksymowych
Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis (13 June, 2022)
Murat Torgutalp, Valeria Rios Rodriguez, Ani Dilbaryan, Fabian Proft, Mikhail Protopopov, Maryna Verba, Judith Rademacher, Hildrun Haibel, Joachim Sieper, Martin Rudwaleit, Denis Poddubnyy

Systemic lupus erythematosus

Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades (16 May, 2022)
Alí Duarte-García, Mehmet Hocaoglu, Maria Valenzuela-Almada, Shirley-Ann Osei-Onomah, Jesse Y Dabit, Alain Sanchez-Rodriguez, Stephanie Q Duong, Rachel E Giblon, Hannah E Langenfeld, Graciela S Alarcón, Charles G Helmick, Cynthia S Crowson
Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus (24 May, 2022)
Thomas Dörner, Yoshiya Tanaka, Ernst R Dow, Alisa E Koch, Maria Silk, Jorge A Ross Terres, Jonathan T Sims, Zhe Sun, Inmaculada de la Torre, Michelle Petri
Biological insights into systemic lupus erythematosus through an immune cell-specific transcriptome-wide association study (24 May, 2022)
Xianyong Yin, Kwangwoo Kim, Hiroyuki Suetsugu, So-Young Bang, Leilei Wen, Masaru Koido, Eunji Ha, Lu Liu, Yuma Sakamoto, Sungsin Jo, Rui-Xue Leng, Nao Otomo, Young-Chang Kwon, Yujun Sheng, Nobuhiko Sugano, Mi Yeong Hwang, Weiran Li, Masaya Mukai, Kyungheon Yoon, Minglong Cai, Kazuyoshi Ishigaki, Won Tae Chung, He Huang, Daisuke Takahashi, Shin-Seok Lee, Mengwei Wang, Kohei Karino, Seung-Cheol Shim, Xiaodong Zheng, Tomoya Miyamura, Young Mo Kang, Dongqing Ye, Junichi Nakamura, Chang-Hee Suh, Yuanjia Tang, Goro Motomura, Yong-Beom Park, Huihua Ding, Takeshi Kuroda, Jung-Yoon Choe, Chengxu Li, Hiroaki Niiro, Youngho Park, Changbing Shen, Takeshi Miyamoto, Ga-Young Ahn, Wenmin Fei, Tsutomu Takeuchi, Jung-Min Shin, Keke Li, Yasushi Kawaguchi, Yeon-Kyung Lee, Yong-Fei Wang, Koichi Amano, Dae Jin Park, Wanling Yang, Yoshifumi Tada, Yu Lung Lau, Ken Yamaji, Zhengwei Zhu, Masato Shimizu, Takashi Atsumi, Akari Suzuki, Takayuki Sumida, Yukinori Okada, Koichi Matsuda, Keitaro Matsuo, Yuta Kochi, Japanese Research Committee on Idiopathic Osteonecrosis of the Femoral Head, Kazuhiko Yamamoto, Koichiro Ohmura, Tae-Hwan Kim, Sen Yang, Takuaki Yamamoto, Bong-Jo Kim, Nan Shen, Shiro Ikegawa, Hye-Soon Lee, Xuejun Zhang, Chikashi Terao, Yong Cui, Sang-Cheol Bae

Systemic sclerosis

Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching (20 May, 2022)
Xiaoyang Yue, Junping Yin, Xiaoqing Wang, Harald Heidecke, Alexander Maximilian Hackel, Xiaoru Dong, Brigitte Kasper, Lifang Wen, Liang Zhang, Kai Schulze-Forster, Juliane Junker, Hanna Grasshoff, Antje Müller, Gerd Wallukat, Ingolf Schimke, Julian Zeiner, Lisa Marie Deckstein, Nicole Mertens, Anja Kerstein-Staehle, Jennifer Elisabeth Hundt, Evi Kostenis, Xinhua Yu, Gabriela Riemekasten, Frank Petersen

Vasculitis

Methylome and transcriptome profiling of giant cell arteritis monocytes reveals novel pathways involved in disease pathogenesis and molecular response to glucocorticoids (15 June, 2022)
Elkyn Estupiñán-Moreno, Lourdes Ortiz-Fernández, Tianlu Li, Jose Hernández-Rodríguez, Laura Ciudad, Eduardo Andrés-León, Laura Carmen Terron-Camero, Sergio Prieto-González, Georgina Espígol-Frigolé, Maria Cinta Cid, Ana Márquez, Esteban Ballestar, Javier Martín

Autoimmunity

Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic component (26 June, 2022)
Yuya Shirai, Yoshimitsu Nakanishi, Akari Suzuki, Hachirou Konaka, Rika Nishikawa, Kyuto Sonehara, Shinichi Namba, Hiroaki Tanaka, Tatsuo Masuda, Moto Yaga, Shingo Satoh, Mayuko Izumi, Yumiko Mizuno, Tatsunori Jo, Yuichi Maeda, Takuro Nii, Eri Oguro-Igashira, The Biobank Japan Project, Takayuki Morisaki, Yoichiro Kamatani, Shingo Nakayamada, Chikako Nishigori, Yoshiya Tanaka, Yoshito Takeda, Kazuhiko Yamamoto, Atsushi Kumanogoh, Yukinori Okada

Osteoporosis

Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease (9 June, 2022)
Edgar Wiebe, Dörte Huscher, Désireé Schaumburg, Andriko Palmowski, Sandra Hermann, Thomas Buttgereit, Robert Biesen, Gerd-Rüdiger Burmester, Yannick Palmowski, Maarten Boers, John H Stone, Christian Dejaco, Frank Buttgereit

Crystal arthropathies

Risk of cardiovascular events in patients having had acute calcium pyrophosphate crystal arthritis (25 May, 2022)
Sara K Tedeschi, Weixing Huang, Kazuki Yoshida, Daniel H Solomon

Images in rheumatology

Clinical image: bone erosions in a young man (13 June, 2022)
Léa Bastard, Benjamin Hagege, Maxime Breban, Hélène Gouze

Letters

Progressive increase in time to referral and persistently severe clinical presentation over the years in autoantibody-negative patients with rheumatoid arthritis in the setting of an early arthritis clinic (29 April, 2022)
Ludovico De Stefano, Bernardo D’Onofrio, Garifallia Sakellariou, Antonio Manzo, Carlomaurizio Montecucco, Serena Bugatti
Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis (22 April, 2022)
Sanne Reijm, Astrid S Brehler, Solbritt Rantapää-Dahlqvist, Atsushi Kawakami, Takahiro Maeda, Shin-ya Kawashiri, Mami Tamai, Diane van der Woude, René E M Toes
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritis (5 May, 2022)
David Simon, Filippo Fagni, Georg Schett
Determination of the minimal clinically important difference (MCID) of the physician global assessment (PGA) in SLE (9 June, 2022)
Erik W Anderson, Meggan Mackay, Giovanni Franchin, Cynthia Aranow
SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection (12 May, 2022)
Enrique Morales, Maria Galindo
Humoral immune-response to a SARS-CoV-2-BNT162b2 booster in inflammatory arthritis patients who received an inactivated virus vaccine (13 April, 2022)
Josefina Durán, Paula Isabel Burgos, Nicole Le Corre, Cinthya Ruiz Tagle, Constanza Martinez-Valdebenito, Mauricio Castro, Valentina Metcalfe, Paula Niemann, M Elvira Balcells

Electronic pages

More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia (31 July, 2020)
Gianfranco Ferraccioli
Response to: ‘More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia’ by Ferraccioli (31 July, 2020)
Emanuel Della-Torre, Corrado Campochiaro, Giulio Cavalli, Giacomo De Luca, Fabio Ciceri, Alberto Zangrillo, Lorenzo Dagna
Correspondence on: ‘Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort’ by Pouletty et al
(5 August, 2020)
Rosa Pino, Ana Carolina Izurieta, María Ríos-Barnés, Sílvia Ricart, Mariona F De Sevilla, Laura Monfort, Cristian Launes, Iván Cano, Laura Lecina, Judith Sánchez Manubens, Juan Manuel Mosquera, Iolanda Jordan, Joan Sánchez de Toledo, Manuel Monsonís, Cristina Esteva, Carmen Muñoz-Almagro, Victòria Fumadó, Clàudia Fortuny, Juan José Garcia Garcia, Antoni Noguera-Julian, Jordi Anton
Response to: ‘Correspondence on ‘Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort’ by Pouletty et al’ by Pino et al
(5 August, 2020)
Naim Ouldali, Marie Pouletty, Johanna Lokmer, Cherine Benzouid, Constance Beyler, Anna Deho, Ulrich Meinzer, Albert Faye, Isabelle Melki
Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis (5 August, 2020)
Mendel E Singer, David C Kaelber, Maria J Antonelli
Response to: ‘Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis’ by Singer et al
(5 August, 2020)
Manuel Francisco Ugarte-Gil, Maximilian F Konig, Peter Korsten, Francis Berenbaum, Alfred Hyoungju Kim, Jeffrey A Sparks
Correspondence on ‘Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist’ by Graef et al
(7 August, 2020)
Chien Hsien Lo, Yu-Hsun Wang, Chin Feng Tsai, Kuei Chuan Chan, Li Ching Li, Tse Hsien Lo, Chun Hung Su, James Cheng-Chung Wei
Response to: ‘Correspondence on ‘Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist’ by Graef et al’ by Lo et al
(7 August, 2020)
Ali Duarte-García, Elizabeth R Graef, Jean W Liew, Maximilian F Konig, Alfred Hyoungju Kim, Jeffrey A Sparks
Correspondence on ‘2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus’ by Aringer et al
(4 August, 2020)
Ran Cui, Qian Wang, Hua Zhang, Shan Wu, Xin-Jian Wan, Sheng-Ming Dai
Response to: ‘‘2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus’ by Aringer et al’ by Cui et al
(4 August, 2020) Free
Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson
Women’s journey in Mexican rheumatology. Comment on ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga et al
(4 August, 2020) Free
Iris J Colunga-Pedraza, Rosa I Arvizu-Rivera, Griselda Serna-Peña, Ana Laura De-Leon-Ibarra, Deshire Alpizar Rodriguez, Alejandra Pérez-Villar, Mayra Alejandra Reyes Soto, Dionicio Angel Galarza-Delgado
Response to: ‘Women’s journey in Mexican rheumatology. Comment on ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga et al’ by Colunga-Pedraza et al
(4 August, 2020) Free
Kanika Monga, Jean Liew
Correspondence to ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga and Liew—gender discrepancies at annual EULAR congresses: towards the gap narrowing (4 August, 2020) Free
Paola Conigliaro, Silvia Laura Bosello, Cristina Iannuccelli, Elisa Gremese, Francesca Romana Spinelli, Marta Vadacca, Maria Sole Chimenti
Response to: ‘Correspondence to ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga and Liew–gender discrepancies at annual EULAR congresses: towards the gap narrowing’ by Conigliaro et al
(4 August, 2020) Free
Kanika Monga, Jean Liew
Case of postpartum axial spondyloarthritis (21 August, 2020) Free
Kazunori Furuhashi, Nanase Honda, Yuji Miyoshi, Naoto Yokogawa
Response to: ‘Case of postpartum axial spondyloarthritis’ by Furuhashi et al
(21 August, 2020) Free
Adel Hoballah, Cédric Lukas, Christophe Leplat, Patrice Taourel, Jean-Baptiste Pialat, Nicolas Sans, Sonia Ramos-Pascual, Mo Saffarini, Catherine Cyteval
Correspondence on ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’ (22 September, 2020) Free
Lara Fallon, Thomas V Jones
Response to: ‘Correspondence on ‘EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update’ by Fallon et al
(22 September, 2020) Free
Xenofon Baraliakos, Laure Gossec, Iain McInnes, Andreas Kerschbaumer, Maarten de Wit, Maxime Dougados, Jette Primdahl, Désirée van der Heijde, Josef S Smolen
Diagnostic value of ultrasound halo count and Halo Score in giant cell arteritis: a retrospective study from routine care (5 August, 2020) Free
Juan Molina Collada, Julia Martínez-Barrio, Belén Serrano-Benavente, Isabel Castrejón, Liz Rocío Caballero Motta, Laura Trives Folguera, José María Álvaro-Gracia
Response to: ‘Diagnostic value of ultrasound halo count and Halo Score in giant cell arteritis: a retrospective study from routine care’ by Molina Collada et al
(5 August, 2020) Free
Kornelis SM van der Geest, Bhaskar Dasgupta
Exaggerated neutrophil extracellular trap formation in Kawasaki disease: a key phenomenon behind the outbreak in western countries? (21 August, 2020)
Kouhei Yamashita, Akifumi Takaori-Kondo, Kiyomi Mizugishi
Response to: ‘Exaggerated neutrophil extracellular trap formation in Kawasaki disease: a key phenomenon behind the outbreak in western countries?’ by Yamashita et al
(21 August, 2020)
Marie Pouletty, Glory Dingulu, Naim Ouldali, Olivier Corseri, Camille Ducrocq, Ulrich Meinzer, Albert Faye, Caroline Galeotti, Isabelle Melki
2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease by Wallace et al
(13 February, 2020) Free
Byung-Woo Yoo, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee
Glucosamine and mortality: a note of caution (11 August, 2020) Free
Richard Conway
Response to: ‘Glucosamine and mortality: a note of caution’ by Conway (11 August, 2020) Free
Zhi-Hao Li, Qing-Mei Huang, Wen-Fang Zhong, Xi-Ru Zhang, Chen Mao
Correspondence to ‘Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study’ by Li et al
(4 August, 2020) Free
Hann-Ziong Yueh, Chih-Jung Yeh, James Cheng-Chung Wei
Response to: ‘Correspondence to ‘Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study’ by Li et al’ by Yueh et al
(4 August, 2020) Free
Zhi-Hao Li, Wen-Fang Zhong, Qing-Mei Huang, Xi-Ru Zhang, Chen Mao
Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al
(4 August, 2020)
Maurizio Benucci, Luca Quartuccio, Francesca Li Gobbi, Arianna Damiani, Valentina Grossi, Maria Infantino, Mariangela Manfredi
Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: ‘Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al’ by Benucci et al
(4 August, 2020)
Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht Vallbracht, Rebecca Hasseli, Alla Skapenko
Terminology and definition of ‘antinuclear antibodies’: history and current debate (30 March, 2020) Free
Robert Daniel Heinrich Markewitz, Klaus-Peter Wandinger
Correction: Cliniclal benefit of 1-year certolizumab pegol(CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritiswas observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial
(11 August, 2022)

Main menu

Table of contents

September 2022 - Volume 81 - 9

Viewpoint

Rheumatoid arthritis

Spondyloarthritis

Systemic lupus erythematosus

Systemic sclerosis

Vasculitis

Autoimmunity

Osteoporosis

Crystal arthropathies

Images in rheumatology

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

September 2022 - Volume 81 - 9

Viewpoint

Rheumatoid arthritis

Spondyloarthritis

Systemic lupus erythematosus

Systemic sclerosis

Vasculitis

Autoimmunity

Osteoporosis

Crystal arthropathies

Images in rheumatology

Letters

Electronic pages

Issue Information